Table 6.
Clinical Management Outcome Subgroup Analyses in Early ID Consult and Standard Care Groups
| Subgroup | Secondary Outcome | Total Subgroup | Early ID Consult | Standard Care | P valuea | P value for time-to-eventb |
|---|---|---|---|---|---|---|
| a. Positive Blood or Nonblood Culture | N = 157 | N = 71 | N = 86 | |||
| Microbiologic tailoring of therapy, n (%) | 124 (79.0) | 57 (80.3) | 67 (77.9) | .72 | .60 | |
| b. De-escalation Recommendation Given | N = 122 | N = 70 | N = 52 | |||
| Antibiotic de-escalation, n (%) | 117 (95.9) | 66 (94.3) | 51 (98.1) | .39 | .39 | |
| De-escalation recommendations followed, n (%) | 114 (93.4) | 63 (90.0) | 51 (98.1) | .14 | ||
| c. Antibiotic Duration Recommendation Given | N = 161 | N = 91 | N = 70 | |||
| Days of antibiotic therapy, median (interquartile range) | 8.0 (6.0, 13.0) | 7.0 (5.0, 12.0) | 10.0 (7.0, 13.0) | .09 | ||
| Recommendations for duration of antibiotic therapy followed, n (%) | 145 (90.1) | 80 (87.9) | 65 (92.9) | .30 |
a χ 2 test, Fisher exact test, or Wilcoxon rank sum test.
b Log-rank test.